Aberrant chromatin regulatory mechanisms in Down syndrome brain
唐氏综合症大脑中异常的染色质调节机制
基本信息
- 批准号:10016388
- 负责人:
- 金额:$ 36.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-15 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAdultAffectAffinityAneuploidyAnimalsBar CodesBehavioralBindingBinding ProteinsBiochemicalBiological AssayBiophysicsBrainBrain regionBromodomainCell SeparationChIP-seqCharacteristicsChromatinChromatin Remodeling FactorChromosome 21Chromosome abnormalityClustered Regularly Interspaced Short Palindromic RepeatsCodeCognitionCognitiveCognitive deficitsComplexCoupledDNADataDepositionDiseaseDorsalDown SyndromeElectrophysiology (science)EmbryoEpigenetic ProcessExpression ProfilingFemaleFunctional disorderGene ExpressionGene Expression ProfilingGenesGeneticGenetic TranscriptionGrowthHippocampus (Brain)HistonesHumanImpaired cognitionImpairmentIn VitroIncidenceIntellectual functioning disabilityInvestigationLaboratoriesLeadLibrariesLive BirthMass Spectrum AnalysisMediatingMediationMethodologyMolecularMolecular AbnormalityMusNeurogliaNeurologicNeuronsNucleosomesOutcomePathway interactionsPatternPhysiologicalPlayPost-Translational Protein ProcessingProcessProteinsProteomicsReaderRecruitment ActivityRegulationRodent ModelRoleSMARCA4 geneSamplingShapesStructureSynapsesSynaptic plasticitySyndromeTestingTranscription CoactivatorTrisomyValidationViralWD Repeatage groupbasecell typecognitive disabilitycombinatorialdosageepigenomeepigenomicsexperimental studygenome-widein vivoinduced pluripotent stem cellliquid chromatography mass spectrometrymalemembermouse Ts65Dnmouse modelnano-liquid chromatographyneurodevelopmentnoveloverexpressionrecruitrelating to nervous systemskeletal abnormalityspatial memorytranscriptometranscriptome sequencing
项目摘要
Project Summary: Maze I
!
Down syndrome (DS) is the most common genetic cause of intellectual disability worldwide resulting from
triplication of chromosome 21 (HSA21) in humans. Despite much progress in understanding the genetics of
DS, the genes encoded on HSA21–and beyond–that directly contribute to intellectual disability, as well as their
associated molecular mechanisms, remain incompletely understood. BRWD1 is an uncharacterized, brain
enriched chromatin `reader' protein encoded within the DS critical region 2 on HSA21. BRWD1 is believed to
act as a transcriptional activator via its proposed interactions with the SWI/SNF chromatin remodeling complex;
however, its roles in the contexts of neurodevelopment and in DS have yet to be studied. Consistent with
previous gene expression analyses in human DS brain, we observe that Brwd1 expression is significantly
elevated in trisomic mice, as well as in neurons derived from hiPSCs from DS subjects. Select histone
posttranslational modifications (PTMs), some of which we have already shown to directly interact with BRWD1,
are also altered in their expression. We have demonstrated that genetic re-normalization of Brwd1 expression
in Ts65Dn mice significantly rescues transcriptional dysplasticity associated with hippocampal LTP and
cognitive deficits in trisomic animals. Furthermore, exogenous Brwd1 overexpression–via viral-mediated
transduction of adult dorsal hippocampal neurons in wildtype animals–also leads to deficits in both contextual
and spatial memory. It is our hypothesis that BRWD1 trisomy in DS brain results in aberrant interactions
between BRWD1 and the epigenetic landscape, thereby contributing to global gene expression
abnormalities and cognitive deficits. We seek to test this hypothesis in the following independent, yet
synergistic Aims: 1) Examine the relationship between Brwd1 trisomy and chromatin dysfunction in DS-like
brain, with an overarching emphasis on a) unbiased assessments of histone PTM expression in DS-like
neurons and glia (+/– Brwd1 rescue) using cell sorting methodologies coupled to histone PTM mass
spectrometry, and b) delineation of direct interactions between BRWD1 and altered histone PTMs using highly
novel `designer' nucleosome-based assays and in vivo validations. 2) Investigate the impact of Brwd1
triplication on gene expression in DS-like brain. We aim to perform unbiased, epigenome-wide analyses of
Brwd1 enrichment–along with associated histone PTMs–in Ts65Dn brain, followed by extensive comparisons
with gene expression profiles obtained using cell-type specific RNA-seq. CRISPR-based manipulations will
subsequently be performed to directly assess Brwd1 target gene contributions to observed behavioral
abnormalities. 3) Explore the impact of Brwd1 triplication on recruitment/activity of specific SWI/SNF chromatin
remodeling complexes in Ts65Dn mouse brain using biochemical and genome-wide assessments. These
experiments will allow us to dissect the functional consequences of abnormal patterns of chromatin regulation
in DS brain and will aid in our understanding of the neuroepigenetic processes associated with brain plasticity.
项目摘要:迷宫我
呢
唐氏综合症(DS)是全世界最常见的智障遗传原因
人类染色体21(HSA21)的一式三重。尽管在理解遗传学方面取得了很多进展
DS,在HSA21上编码的基因,以及直接导致智力残疾及其的基因
相关的分子机制,仍然不完全理解。 BRWD1是一个未表征的大脑
在HSA21上的DS临界区域2中编码的富集染色质“读取器”蛋白。据信BRWD1
通过其提出的与SWI/SNF染色质重塑复合物的相互作用充当转录激活剂;
但是,它在神经发育和DS中的角色尚未研究。与
以前的基因表达分析在人DS脑中,我们观察到BRWD1表达显着
在trisomic小鼠以及来自DS受试者hipsC的神经元中升高。选择组蛋白
翻译后修改(PTM),我们已经证明其中一些与BRWD1直接相互作用,
他们的表达也有所改变。我们已经证明了BRWD1表达的遗传重新归一化
在TS65DN小鼠中,与海马LTP和
三方动物的认知缺陷。此外,外源BRWD1过表达 - 病毒介导
在野生型动物中转导成年背部神经元 - 也导致在这两个上下文中定义
和空间内存。我们的假设是,DS脑中的BRWD1三体性导致异常相互作用
在BRWD1和表观遗传景观之间,从而有助于全球基因表达
异常和认知缺陷。我们试图通过以下独立来检验这一假设
协同目的:1)检查DS样中的BRWD1三体和染色质功能障碍之间的关系
大脑,总体上强调a)对DS样中组蛋白PTM表达的无偏评估
神经元和神经元(+/– BRWD1救援)使用与组蛋白PTM质量耦合的细胞分选方法
光谱法和b)使用高度使用BRWD1和更改Hisstone PTM之间的直接相互作用的描述
新颖的“设计师”基于核小体的测定和体内验证。 2)研究BRWD1的影响
DS样脑中基因表达的一式陈述。我们的目标是对宽依性基因组进行无偏见的分析
BRWD1富集与相关组蛋白PTMS - 在TS65DN脑中,然后进行广泛的比较
使用细胞类型特异性RNA-seq获得的基因表达谱。基于CRISPR的操作会
随后进行直接评估BRWD1靶基因对观察到的行为的贡献
异常。 3)探索BRWD1三次固定对特定SWI/SNF染色质募集/活动的影响
使用生化和全基因组评估,在TS65DN小鼠脑中重塑复合物。这些
实验将使我们能够剖析染色质调节异常模式的功能后果
在DS大脑中,将有助于我们理解与大脑可塑性相关的神经毛状过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ian S. Maze其他文献
Ian S. Maze的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ian S. Maze', 18)}}的其他基金
Molecular studies of neural histone monoaminylation in normal and aberrant brain plasticity
正常和异常大脑可塑性中神经组蛋白单胺化的分子研究
- 批准号:
10532731 - 财政年份:2019
- 资助金额:
$ 36.02万 - 项目类别:
Aberrant chromatin regulatory mechanisms in Down syndrome brain
唐氏综合症大脑中异常的染色质调节机制
- 批准号:
10438763 - 财政年份:2019
- 资助金额:
$ 36.02万 - 项目类别:
Molecular studies of neural histone monoaminylation in normal and aberrant brain plasticity
正常和异常大脑可塑性中神经组蛋白单胺化的分子研究
- 批准号:
10310479 - 财政年份:2019
- 资助金额:
$ 36.02万 - 项目类别:
Aberrant chromatin regulatory mechanisms in Down syndrome brain
唐氏综合症大脑中异常的染色质调节机制
- 批准号:
10665587 - 财政年份:2019
- 资助金额:
$ 36.02万 - 项目类别:
Aberrant chromatin regulatory mechanisms in Down syndrome brain
唐氏综合症大脑中异常的染色质调节机制
- 批准号:
9815589 - 财政年份:2019
- 资助金额:
$ 36.02万 - 项目类别:
Roles for histone monoaminylation in cocaine-induced transcriptional and behavioral plasticity
组蛋白单胺化在可卡因诱导的转录和行为可塑性中的作用
- 批准号:
9915869 - 财政年份:2016
- 资助金额:
$ 36.02万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
In vivo precision genome editing to correct genetic disease
体内精准基因组编辑以纠正遗传疾病
- 批准号:
10771419 - 财政年份:2023
- 资助金额:
$ 36.02万 - 项目类别:
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells
桥粒斑蛋白对肺泡2型细胞肺纤维化的遗传贡献机制研究
- 批准号:
10736228 - 财政年份:2023
- 资助金额:
$ 36.02万 - 项目类别:
Endogenous retrovirus in joint aging and osteoarthritis development
内源性逆转录病毒在关节衰老和骨关节炎发展中的作用
- 批准号:
10719364 - 财政年份:2023
- 资助金额:
$ 36.02万 - 项目类别:
Defining mechanisms of metabolic-epigenetic crosstalk that drive glioma initiation
定义驱动神经胶质瘤发生的代谢-表观遗传串扰机制
- 批准号:
10581192 - 财政年份:2023
- 资助金额:
$ 36.02万 - 项目类别:
Combined bromodomain and CDK4/6 inhibition in NUT Carcinoma and other solid tumors
溴结构域和 CDK4/6 联合抑制 NUT 癌和其他实体瘤
- 批准号:
10577265 - 财政年份:2023
- 资助金额:
$ 36.02万 - 项目类别: